N-(2-Hydroxyethyl)oleamide (OEA): Chemical Properties and Procurement Guide
N-(2-Hydroxyethyl)oleamide, commonly known as Oleoylethanolamide (OEA), is a fascinating endogenous lipid that garners significant attention in pharmacological research. Its well-defined chemical properties and biological activities make it a critical intermediate for various therapeutic applications, particularly in metabolic health. For professionals seeking to buy this compound, understanding its specifications and how to procure it effectively is key.
As a reputable manufacturer and supplier of specialized chemicals, our goal is to provide researchers and formulators with access to high-purity Oleoylethanolamide. This article outlines the key chemical characteristics of OEA and guides you on procurement best practices.
Understanding the Chemical Profile of OEA
Oleoylethanolamide has the chemical name N-(2-Hydroxyethyl)oleamide, with the CAS Number 111-58-0. Its molecular formula is C20H39NO2, and it has a molecular weight of approximately 325.53 g/mol. This composition is crucial for its interaction with biological targets, most notably the PPAR-α receptor.
Key Physical and Chemical Properties:
- Appearance: Typically presented as a white to off-white solid. This physical state facilitates handling and incorporation into various formulations.
- Melting Point: Ranges between 50-60°C, indicating a stable solid form under standard laboratory and storage conditions.
- Purity: High purity is essential for its intended applications. Our OEA is manufactured to a purity level of ≥98%, ensuring reliable performance.
- Solubility: While not detailed in this excerpt, OEA generally exhibits solubility in organic solvents, typical for fatty acid amides.
- Density: Reported as 0.915 g/cm³, which is common for lipid-based molecules.
Procuring High-Quality Oleoylethanolamide
When considering to buy Oleoylethanolamide, it is imperative to partner with a reliable Oleoylethanolamide manufacturer. Our commitment as a supplier in China extends beyond merely providing the chemical; we ensure that each product is accompanied by a Certificate of Analysis (CoA) detailing its purity, physical properties, and safety data. This transparency is vital for pharmaceutical research and development.
We understand that securing a consistent and high-quality supply of N-(2-Hydroxyethyl)oleamide is critical for project timelines and success. Therefore, we maintain rigorous quality control throughout our manufacturing process. By choosing us as your OEA supplier, you gain access to a product that is not only competitively priced but also manufactured to meet the demanding standards of the pharmaceutical industry.
The Importance of OEA in Pharmaceutical Applications
OEA's role as a PPAR-α agonist makes it invaluable for developing therapeutics targeting obesity and metabolic syndrome. By influencing satiety and promoting fat metabolism, OEA offers a pathway to novel weight management solutions. Furthermore, its impact on lipid profiles suggests potential benefits for conditions like arteriosclerosis. Researchers looking to buy OEA for these applications need a dependable source that guarantees the integrity of the compound.
We are dedicated to supporting the scientific community by providing essential chemical intermediates like Oleoylethanolamide. As a leading OEA supplier in China, we invite you to connect with us to discuss your specific requirements, explore our competitive Oleoylethanolamide price points, and secure a dependable supply for your groundbreaking research.
Perspectives & Insights
Chem Catalyst Pro
“Therefore, we maintain rigorous quality control throughout our manufacturing process.”
Agile Thinker 7
“By choosing us as your OEA supplier, you gain access to a product that is not only competitively priced but also manufactured to meet the demanding standards of the pharmaceutical industry.”
Logic Spark 24
“The Importance of OEA in Pharmaceutical Applications OEA's role as a PPAR-α agonist makes it invaluable for developing therapeutics targeting obesity and metabolic syndrome.”